Can an AI app give a voice to brain tumor patients?

NCT ID NCT07732140

Not yet recruiting Symptom relief Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app called LISTEN can help people with brain tumors who have trouble speaking (aphasia) communicate more easily. The app uses artificial intelligence to adapt to each user's needs and can be used with voice input and output. Researchers will see if the app is practical and acceptable for patients and their care partners.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LISTEN, an AI-based augmentative and alternative communication (AAC) smartphone app
What this could lead to: If it works, this could provide a practical, personalized communication tool for people with brain tumors who struggle to speak.
What could go wrong: This is an early feasibility study with only 80 participants. The app may not be user-friendly or effective for everyone, and it requires a smartphone and comfort with AI technology.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aphasia brain cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APHASIA MALIGNANT BRAIN TUMOR

Contacts and locations

Locations

Brigham & Woman's Hospital

Boston, Massachusetts, 02115, United States
Dana-Farber Cancer Center

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.